Biomedical Engineering Reference
In-Depth Information
Daemen J and Serruys PW. 2007. Drug-eluting stent update 2007: Part I. A survey of current and
future generation drug-eluting stents: Meaningful advances or more of the same? Circulation
116:316-328.
Deconinck E, Sohier J, De Scheerder I et al. 2008. Pharmaceutical aspects of drug eluting stents.
J Pharm Sci 97:5047-5060.
Degertekin M, Serruys PW, Foley DP et al. 2002. Persistent inhibition of neointimal hyperplasia after
sirolimus-eluting stent implantation: Long-term (up to 2 years) clinical, angiographic, and
intravascular ultrasound follow-up. Circulation 106:1610-1613.
de Jaegere P, Serruys PW, van Es GA et al. 1994. Recoil following Wiktor stent implantation for res-
tenotic lesions of coronary arteries. Cathet Cardiovasc Diagn 32(2):147-156.
De Jaegere PP, De Feyter PJ, Van der Giessen WJ et al. 1994. Intracoronary stents: A review of the
experience with five different devices in clinical use. J Interv Cardiol 7(2):117-128.
Doyle B and Holmes Jr DR . 2009. Next generation drug-eluting stents: Focus on bioabsorbable plat-
forms and polymers. Med Devices Evidence Res 2:47-55.
Duckers HJ, Silber S, de Winter R et al. 2007a. Circulating endothelial progenitor cells predict angio-
graphic and intravascular ultrasound outcome following percutaneous coronary interven-
tions in the HEALING-II trial: Evaluation of an endothelial progenitor cell capturing stent.
EuroIntervention 3:67-75.
Duckers HJ, Soullié T, den Heijer P et al. 2007b. Accelerated vascular repair following percutaneous
coronary intervention by capture of endothelial progenitor cells promotes regression of neointi-
mal growth at long term follow-up: Final results of the Healing II trial using an endothelial
progenitor cell capturing stent (Genous R stent)™. EuroIntervention 3:350-358.
Duda SH, Poerner TC, Wiesinger B et al. 2003. Drug-eluting stents: Potential applications for periph-
2003. Drug-eluting stents: Potential applications for periph-
eral arterial occlusive disease, J Vasc Interv Radiol 14:291-301.
Eberhart RC, Su SH, Nguyen KT et al. 2003. Bioresorbable polymeric stents: Current status and future
promise. J Biomater Sci Polym Ed 14(4):299-312.
Eggebrecht H, Rodermann J, Hunold P et al. 2005. Images in cardiovascular medicine. Novel mag-
netic resonance-compatible coronary stent: The absorbable magnesium-alloy stent. Circulation
112(18):e303-e304.
Fan W, Johnson DM, Feldman MD . 2009. Metallic stents coated with bioabsorbable polymers, an
overview of polymer technology as a drug-carrier mechanism. Cardiac Interv Jun/July: 42-49.
Farb A, Burke AP, Kolodgie FD et al. 2003. Pathological mechanisms of fatal late coronary stent
thrombosis in humans. Circulation 108:1701-1706.
Farb A, Sangiorgi G, Carter AJ et al. 1999. Pathology of acute and chronic coronary stenting in
humans. Circulation 99:44-52.
Faxon DP. 2002. Systemic drug therapy for restenosis “Déjà Vu all over again.” Circulation
106:2296-2298.
Finkelstein A, McClean D, Kar S et al. 2003. Local drug delivery via a coronary stent with program-
mable release pharmacokinetics. Circulation 107:777-784.
Finn AV, Kolodgie FD, Harnek J et al. 2005. Differential response of delayed healing and persis-
tent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation
112:270-278.
Finn AV, Nakazawa G, Joner M et al. 2007. Vascular responses to drug eluting stents: Importance of
delayed healing. Arterioscler Thromb Vasc Biol 27:1500-1510.
Fischman DL, Leon MB, Baim DS et al. 1994. The Stent Restenosis Study Investigators. A randomized
comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary
artery disease. N Engl J Med 331:496-501.
Fishell TA, Dishmon D, Elhaddi A et al. 2009. The perfect drug-eluting stent: Goals for stent, polymer,
and drug development. Cardiac Interv Today June/July:29-35.
Fortin JB and Lu TM. 2004. Chemical Vapour Deposition Polymerization: The Growth and Properties of
Parylene Thin Films . Kluwer Academic Publishers, Boston USA.
Gottsauner-Wolf M, Moliterno DJ, Lincoff AM et al. 1996. Restenosis—an open file. Clin Cardiol
19(5):347-356.
et al. 2003. Drug-eluting stents: Potential applications for periph-
2003. Drug-eluting stents: Potential applications for periph-
Search WWH ::




Custom Search